Abel Hall LLC
AZN icon

Abel Hall LLC’s AstraZeneca AZN Stock Holding History

Abel Hall LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.01M Buy
6,276
+3,270
+109% +$545K 0.18% 74
2026
Q2 		$570K Sell
3,006
-3,665
-55% -$689K 0.1% 198
2026
Q1 		$1.32M Buy
6,671
+3,462
+108% +$668K 0.28% 46
2025
Q4 		$590K Buy
3,209
+368
+13% +$64.5K 0.14% 132
2025
Q3 		$436K Buy
2,841
+113
+4% +$17.1K 0.18% 111
2025
Q2 		$381K Sell
2,728
-398
-13% -$55.8K 0.18% 118
2025
Q1 		$459K Buy
3,126
+900
+40% +$130K 0.28% 58
2024
Q4 		$292K Sell
2,226
-16
-0.7% -$2.24K 0.19% 92
2024
Q3 		$349K Sell
2,242
-65
-3% -$10.5K 0.23% 77
2024
Q2 		$360K Buy
2,307
+389
+20% +$58.5K 0.25% 65
2024
Q1 		$260K Buy
1,918
+76
+4% +$10.1K 0.19% 94
2023
Q4 		$248K Buy
+1,842
New +$239K 0.21% 86

Other funds holding AZN

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Generali Asset Management
Generali Asset Management Trieste, Italy $5.73B AUM 29.6% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Abel Hall LLC's AZN Position: Q3 2026 in Review

Abel Hall LLC increased its AstraZeneca (AZN) stake by 109% in Q3 2026, buying an estimated $545K and bringing the position to 6,276 shares worth $1.01M. The position accounts for 0.18% of the portfolio, ranked #74.

Abel Hall LLC first reported a position in AZN in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.32M in Q1 2026. 448 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Abel Hall LLC held 6,276 shares of AstraZeneca worth $1.01M as of Q3 2026.
  • Abel Hall LLC bought 3,270 AstraZeneca shares in Q3 2026, an estimated $545K.
  • AstraZeneca made up 0.18% of Abel Hall LLC's portfolio in Q3 2026, its #74 holding.
  • Abel Hall LLC first reported a position in AstraZeneca in Q4 2023 and has held it in 12 quarters since.
  • Abel Hall LLC's AstraZeneca position peaked at $1.32M in Q1 2026.
  • 448 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.